Abstract

Some Drugs for Maintenance Treatment of Opioid Use Disorder

Full Text

Published Version
Open DOI Link

Topics from this Paper

  • Treatment Of Opioid Use Disorder
  • Opioid Use
  • Comparison Table
  • Treatment Of Disorder
  • Maintenance Treatment

Create a personalized feed of these topics

Get Started

Get access to 115M+ research papers

Discover from 40M+ Open access, 2M+ Pre-prints, 9.5M Topics and 32K+ Journals.

Sign Up Now! It's FREE

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Consensus Recommendations on the Treatment of Opioid Use Disorder in the Emergency Department
  • Annals of Emergency Medicine
  • Sep 1, 2021
Relevant
Not Relevant
Integrated hepatitis C treatment is associated with improved retention and success in outpatient treatment for opioid use disorder at a private clinic
  • Frontiers in Psychiatry
  • Sep 14, 2022
Relevant
Not Relevant
Newly Developed Dopamine D3Receptor Antagonists,R-VK4-40 andR-VK4-116, Do Not Potentiate Cardiovascular Effects of Cocaine or Oxycodone in Rats
  • Journal of Pharmacology and Experimental Therapeutics
  • Sep 27, 2019
Relevant
Not Relevant
Familial perceptions of appropriate treatment types and goals for a family member who has opioid use disorder
  • Drug and Alcohol Dependence
  • Apr 1, 2021
Relevant
Not Relevant
Sex as a Biological Variable and Gender as a Social Construct in the Treatment of Opioid Use Disorder
  • Apr 20, 2023
Relevant
Not Relevant
Document Provides Inpatient Guidelines for Medication Treatment of Opioid Use Disorder
  • Psychiatric News
  • Jan 1, 2023
Relevant
Not Relevant
Rapid Micro-induction of Buprenorphine/Naloxone for Opioid Use Disorder in a Critically ill Intubated Patient: A Case Report
  • Journal of Addiction Medicine
  • Jul 7, 2020
Relevant
Not Relevant
Associations Between Patient-Reported Experiences with Opioid Use Disorder Treatment and Unmet Treatment Needs and Discontinuation Among Virginia Medicaid Members.
  • Substance abuse
  • Jul 1, 2023
Relevant
Not Relevant
HIV Stigma, HIV status disclosure, and ART adherence in the context of an integrated opioid use disorder and HIV treatment setting in Dar es Salaam, Tanzania
  • AIDS Care
  • Jan 2, 2023
Relevant
Not Relevant
Enhancing Treatment Access and Effectiveness: Toward Patient-Centered Models of Care
  • Jan 1, 2019
Relevant
Not Relevant
Knowledge of and concerns about long-acting reversible contraception among women in medication-assisted treatment for opioid use disorder
  • Contraception
  • Nov 1, 2017
Relevant
Not Relevant
A retrospective cohort study of medication dispensing at pharmacies: Administration matters!
  • Drug and Alcohol Dependence
  • Aug 1, 2021
Relevant
Not Relevant
Communication between patients, peers, and care providers through a mobile health intervention supporting medication-assisted treatment for opioid use disorder
  • Patient Education and Counseling
  • Jul 1, 2022
Relevant
Not Relevant
Waiting times disparities for medication-assisted therapy among opioid use disorder treatment population in the United States.
  • Journal of addictive diseases
  • Sep 9, 2022
Relevant
Not Relevant
Waiting times disparities for medication-assisted therapy among opioid use disorder treatment population in the United States
  • Journal of Addictive Diseases
  • Aug 25, 2022
Relevant
Not Relevant
READ MORE FROM

The Medical letter on drugs and therapeutics

Sulbactam/durlobactam (Xacduro) for Acinetobacter pneumonia.
Just Published
  • The Medical letter on drugs and therapeutics
  • Nov 27, 2023
Relevant
Not Relevant
Shockwave therapy for erectile dysfunction.
Just Published
  • The Medical letter on drugs and therapeutics
  • Nov 27, 2023
Relevant
Not Relevant
In brief: GI effects of GLP-1 receptor agonists.
Just Published
  • The Medical letter on drugs and therapeutics
  • Nov 27, 2023
Relevant
Not Relevant
Ritlecitinib (Litfulo) for severe alopecia areata.
Open Access
Just Published
  • The Medical letter on drugs and therapeutics
  • Nov 27, 2023
Relevant
Not Relevant
Addendum.
Just Published
  • The Medical letter on drugs and therapeutics
  • Nov 27, 2023
Relevant
Not Relevant
Etrasimod (Velsipity) for ulcerative colitis.
Open Access
Just Published
  • The Medical letter on drugs and therapeutics
  • Nov 27, 2023
Relevant
Not Relevant
COVID-19 update: New Novavax vaccine formulation for 2023-2024.
  • The Medical letter on drugs and therapeutics
  • Nov 13, 2023
Relevant
Not Relevant
Correction.
  • The Medical letter on drugs and therapeutics
  • Nov 13, 2023
Relevant
Not Relevant
In brief: Empagliflozin (Jardiance) for chronic kidney disease.
  • The Medical letter on drugs and therapeutics
  • Nov 13, 2023
Relevant
Not Relevant
Antiviral drugs for influenza for 2023-2024.
  • The Medical letter on drugs and therapeutics
  • Nov 13, 2023
Relevant
Not Relevant